Rocket Lab shares are lower today as the market focuses on a recent SEC filing tied to an equity distribution agreement that permits the company to sell up to $1 billion of common stock from time to time through sales agents. Even if no immediate issuance occurs, ATMs often pressure shares because they increase the perceived supply of stock and introduce uncertainty around timing and pricing.

The selloff reflects dilution sensitivity: incremental equity capacity can reduce per-share value if issued, and it can also cap near-term upside as investors price in potential selling into strength. The move is also consistent with a “risk-off” reaction seen when high-beta aerospace/space names face financing headlines, particularly after strong prior gains.

Key swing factors include whether Rocket Lab provides clarity on expected ATM usage, size and cadence of potential sales, and the specific uses of proceeds (e.g., Neutron development, launch operations, or Space Systems capacity). Investors will also be watching upcoming Electron/HASTE launch cadence and any Neutron schedule updates, as positive execution milestones can help counterbalance dilution concerns.